semaglutide mental health side effects Common And Rare Of For Weight Loss Penn study focuses on semaglutide
Description
According to data from the 72-week SURMOUNT-1 trial, participants on the maximum dose experienced an average weight loss of 18% of their body weight , with 36.2% achieving a significant reduction in weight[1]
doi:10.2147/jir.s470520
MR uses genetic variants as instrumental variables (IVs) to infer causality between an exposure and an outcome, assessing whether observed associations indicate causal relationships
Study dropouts were more frequent with 100 mg of resmetirom than with placebo in the first 12 weeks and similar in frequency across the three study arms from week 12 to week 52
